U.S. Food and Drug Administration (FDA) PDUFA goal date for ONS-5010 is August 27, 2025. Off-label repackaged bevacizumab is one of the most frequently used first-line anti-VEGF treatments in Europe ...

WASHINGTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The U.S. economy is expected to remain resilient in 2026 despite a moderation in growth, according to the 2026 Equipment Leasing & Finance U.S. Economic ...

Vanguard has released its annual outlook on the global economy and financial markets. This year’s report, “AI exuberance: Economic upside, stock market downside,” provides investors with an economic ...

Dialing down uncertainty, reducing vulnerabilities, and investing in innovation can help deliver durable economic gains. In April, the United States shook global trade norms by announcing sweeping ...